|
|
||||||||
Basic Science Investigation |
1 Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York; 2 Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York; 3 Cyclotron and Radiochemistry Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York; 4 Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 5 Memorial Hospital Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York
Correspondence: For correspondence or reprints contact: Ronald G. Blasberg, MD, Departments of Neurology and Radiology, MH (Box 52), Molecular Pharmacology and Chemistry Program, SKI, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, New York 10021. E-mail: blasberg{at}neuro1.mskcc.org
The norepinephrine transporter (NET) has recently been suggested as a useful reporter gene. We have extended this effort by constructing an internal ribosomal entry site (IRES)-linked hNET-green fluorescent protein (GFP) hybrid reporter gene for both nuclear and optical imaging. Methods: A retroviral vector pQCXhNET-IRES-GFP was constructed and used to generate several reporter cell lines and xenografts. Transduced cells were sorted by fluorescence-activated cell sorting based on GFP expression and used for both in vitro and in vivo imaging studies. Results: The transduced reporter cells accumulated 123I- or 124I-labeled metaiodobenzylguanidine (MIBG) to high levels compared with the wild-type parent cell lines. Differences in MIBG accumulation between cell lines were primarily due to differences in influx (K1) rather than efflux (k2). The estimated MIBG distribution volumes (Vd) for transduced Jurkat, C6, and COS-7 cells were 572 ± 13, 754 ± 25, and 1,556 ± 38 mL/g, respectively. A correlation between radiotracer accumulation (K1) and GFP fluorescence intensity was also demonstrated. Sequential imaging studies of mice bearing pQCXhNET-IRES-GFP transduced and wild-type C6 xenografts demonstrated several advantages of 124I-MIBG small-animal PET compared with 123I-MIBG
-camera/SPECT. This was primarily due to the longer half-life of 124I and to the retention and slow clearance (half-time, 63 ± 6 h) of MIBG from transduced xenografts compared with that from wild-type xenografts (half-time, 12 ± 1 h) and other organs (half-time, 2.621 h). Very high radioactivity ratios were observed at later imaging times; at 73 h after 124I-MIBG injection, the C6/hNET-IRES-GFP xenograft-to-muscle ratio was 293 ± 48 whereas the C6 xenograft-to-muscle ratio was 0.71 ± 0.19. Conclusion: These studies demonstrate the potential for a wider application of hNET reporter imaging and the future translation to patient studies using radiopharmaceuticals that are currently available for both SPECT and PET.
Key Words: human norepinephrine transporter 124I-MIBG 123I-MIBG PET
-camera SPECT molecular imaging reporter gene
* Contributed equally to this work.
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
P. Brader, K. J. Kelly, N. Chen, Y. A. Yu, Q. Zhang, P. Zanzonico, E. M. Burnazi, R. E. Ghani, I. Serganova, H. Hricak, et al. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene Clin. Cancer Res., June 1, 2009; 15(11): 3791 - 3801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kang and J.-K. Chung Molecular-Genetic Imaging Based on Reporter Gene Expression J. Nucl. Med., June 1, 2008; 49(Suppl_2): 164S - 179S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Likar, K. Dobrenkov, M. Olszewska, E. Vider, L. Shenker, S. Cai, N. Pillarsetty, H. Hricak, and V. Ponomarev A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs J. Nucl. Med., May 1, 2008; 49(5): 713 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Culver, W. Akers, and S. Achilefu Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities J. Nucl. Med., February 1, 2008; 49(2): 169 - 172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |